On the same day that Sanofi and GSK announced the start of a new Phase 2 study of their delayed adjuvanted recombinant protein-based Covid-19 vaccine candidate, Sanofi...
French drugmaker Sanofi has named its new company for major Active Pharmaceutical ingredients EuroAPI and announced Karl Rotthier as its future CEO with effect from Jan...
French pharma Sanofi is once again boosting its immunotherapy capabilities, this time with the acquisition of UK biotech Kymab. The company will make an upfront payment...
French drugmaker Sanofi has completed its acquisition of US-based Principia Biopharma for $100 per share in cash. The takeover worth altogether $3.7 billion was sealed...
Both the Sanofi/GlaxoSmithKline partnership and US vaccine producer Moderna this week announced new advance purchase agreements with Canada for their Covid-19 vaccine...
Sanofi and GSK have agreed a deal with the EU to supply up to 300 million doses of their recombinant protein-based Covd-19 vaccine pending regulatory approval, which is...